Taro Pharmaceutical
TARO
#5070
Rank
S$2.08 B
Marketcap
S$55.49
Share price
0.00%
Change (1 day)
4.17%
Change (1 year)

Taro Pharmaceutical (TARO) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : S$0.49 Billion

According to Taro Pharmaceutical's latest financial reports the company's total liabilities are S$0.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Taro Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-03-31S$0.53 B-14.53%
2022-03-31S$0.62 B-34.2%
2021-03-31S$0.95 B190.74%
2020-03-31S$0.32 B8.4%
2019-03-31S$0.30 B3.92%
2018-03-31S$0.29 B-3.12%
2017-03-31S$0.30 B-10.85%
2016-03-31S$0.33 B-23.11%
2015-03-31S$0.43 B32.54%
2014-03-31S$0.33 B24.01%
2013-03-31S$0.26 B
2011-12-31S$0.29 B31.44%
2010-12-31S$0.22 B-43.7%
2009-12-31S$0.39 B-10.95%
2008-12-31S$0.44 B-7.01%
2007-12-31S$0.47 B-17.37%
2006-12-31S$0.57 B-17.82%
2005-12-31S$0.69 B30.72%
2004-12-31S$0.53 B17.79%
2003-12-31S$0.45 B139.02%
2002-12-31S$0.19 B15.86%
2001-12-31S$0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$149.33 B 30,006.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.26 B 20,113.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$146.63 B 29,460.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.10 B 8,388.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$79.14 B 15,855.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$80.76 B 16,182.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland